Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
845 INR | +0.90% | -1.51% | -9.17% |
Business Summary
Number of employees: 12,220
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Financing
100.0
%
| 72,927 | 52.1 % | 90,867 | 100.0 % | +24.60% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 85,413 | 61.0 % | 90,867 | 100.0 % | +6.39% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rupen Jhaveri
PSD | President | - | 21-11-30 |
Vivek Valsaraj
PSD | President | 51 | - |
Goel Upma
DFI | Director of Finance/CFO | - | 22-08-17 |
Bipin Singh
CMP | Compliance Officer | 56 | 19-07-29 |
Viral Gandhi
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Director/Board Member | 65 | 99-07-31 | |
Director/Board Member | 43 | 09-03-31 | |
Hitesh Dhaddha
IRC | Investor Relations Contact | - | - |
S. K. Honnesh
LAW | General Counsel | - | - |
Corporate Secretary | 66 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 39 | 17-05-11 | |
Chairman | 68 | - | |
Director/Board Member | 65 | 99-07-31 | |
Shikha Sharma
BRD | Director/Board Member | 64 | 22-03-30 |
Director/Board Member | 51 | 21-10-06 | |
Kunal Bahl
BRD | Director/Board Member | 40 | 20-10-13 |
Anjali Bansal
BRD | Director/Board Member | 53 | 20-11-18 |
Director/Board Member | 63 | 22-02-09 | |
Rajiv Mehrishi
BRD | Director/Board Member | - | 22-05-25 |
- | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 224,663,700 | 114,534,994 ( 50.98 %) | 1,124,051 ( 0.5003 %) | 50.98 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
PIRAMAL PHARMA LIMITED 0.82% | 10,834,462 | 0.82% | 16,744,878 $ |
Company contact information
Piramal Enterprises Ltd.
Piramal Ananta, LBS Marg Agastya Corporate Park
400070, Mumbai
+91 22 3802 3000
http://www.piramal.comGroup companies
Name | Category and Sector |
---|---|
Piramal Fund Management Pvt Ltd.
Piramal Fund Management Pvt Ltd. Investment ManagersFinance Piramal Fund Management Pvt Ltd. (Piramal FM) is the private equity and venture capital subsidiary of Piramal Enterprises Ltd. (BSE: 500302) in India. Led by entrepreneur-turned-professional, Mr. Ramesh Jogani, Piramal FM is backed by extensive team experience and a developer's perspective in selecting projects with an inherent assurance of delivery and successful implementation. Established in 2006, the firm advises over USD 450 Million and has invested across various real estate projects in Mumbai, Chennai, Bangalore, Hyderabad and Pune. Piramal FM is headquartered in Mumbai and provides investors with access to their understanding of Indian real estate and their network of partners. |
Investment Managers
|
PHI Fininvest Pvt Ltd.
PHI Fininvest Pvt Ltd. Financial ConglomeratesFinance PHI Fininvest Pvt Ltd. provides financial intermediation services. The company is headquartered in Mumbai, India. |
Financial Conglomerates
|
Piramal Systems & Technologies Pvt Ltd.
| |
Piramal Finance Pvt Ltd.
Piramal Finance Pvt Ltd. Real Estate DevelopmentFinance Piramal Finance Pvt Ltd. provides financial services to business of real estate. The company is headquartered in Mumbai, India. |
Real Estate Development
|
Convergence Chemicals Pvt Ltd.
Convergence Chemicals Pvt Ltd. Chemicals: SpecialtyProcess Industries Convergence Chemicals Pvt Ltd. develops and manufactures specialty fluorochemicals, primarily starting material . The company was founded in November 2014 and is headquartered in Bharuch, India. |
Chemicals: Specialty
|
Piramal Consumer Products Pvt Ltd.
Piramal Consumer Products Pvt Ltd. Investment ManagersFinance Piramal Consumer Products Pvt Ltd. operates as a consumer product division of Piramal Enterprise's Healthcare. It invests and acquires pharmaceuticals and cosmetic products producer firms. The company was founded on July 18, 2012 and is headquartered in Mumbai, India. |
Investment Managers
|
DRG Analytics & Insights Pvt Ltd.
| |
Pharmaceuticals: Major
| |
Piramal Asset Management Pvt Ltd.
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.65% | 51.37B | |
-4.53% | 31.1B | |
+55.33% | 27.48B | |
+18.67% | 23.46B | |
+3.90% | 16.14B | |
-11.09% | 11.34B | |
+17.67% | 10.78B | |
+13.24% | 7.84B | |
-28.04% | 7.56B |
- Stock Market
- Equities
- PEL Stock
- PEL Stock
- Company Piramal Enterprises Limited